🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact The Pharmacist's Role: How Community Pharmacies in Ireland and the UK Are Adapting as Patients Bypass High-Street Stores for Direct Delivery GLP-1 Therapeutics and Clinical Research Updates: Brain Reward Mapping, Oral Small Molecules, and Triple-Agonist Horizons Rinn Pharma & Biopharma Joins NordicPharmaTrain Network to Accelerate European Research & Advanced Manufacturing Markets Surge as August Opens: $400B Big Pharma Merger Speculation & AstraZeneca Deal Talks Grab Global Headlines Trump’s September Visit to Ireland: Agenda, Economic Policy Evaluation & U.S.-Irish Trade Implications Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact The Pharmacist's Role: How Community Pharmacies in Ireland and the UK Are Adapting as Patients Bypass High-Street Stores for Direct Delivery GLP-1 Therapeutics and Clinical Research Updates: Brain Reward Mapping, Oral Small Molecules, and Triple-Agonist Horizons Rinn Pharma & Biopharma Joins NordicPharmaTrain Network to Accelerate European Research & Advanced Manufacturing Markets Surge as August Opens: $400B Big Pharma Merger Speculation & AstraZeneca Deal Talks Grab Global Headlines Trump’s September Visit to Ireland: Agenda, Economic Policy Evaluation & U.S.-Irish Trade Implications
Industry

Inside Fierce Summit 2026: A Founder's Perspective on Building CareSight and Empowering Women in Tech

Sreepriya Prasannan
Sreepriya Prasannan
Speed:
Inside Fierce Summit 2026: A Founder's Perspective on Building CareSight and Empowering Women in Tech

On the 5th of June 2026, Dogpatch Labs in Dublin was filled with an electric energy that is rare to find. Fierce Summit 2026 brought together 100 early-stage women tech founders, along with some of the most seasoned investors, founders, and operators in the global tech ecosystem. As the founder of Priya Life Science and my MedTech startup, CareSight, I was honoured to be in the room.

Fierce Summit is designed to bypass the usual corporate fluff and focus on what early-stage founders actually need: direct access to active VCs, candid roundtables on GTM and fundraising, and tactical advice from operators who have built, scaled, and exited global ventures. From the morning keynotes to the evening networking reception, it was a day of high-signal, zero-fluff insights.

The Highlight: Razor-Sharp 1:1 Mentoring

One of the most valuable aspects of the day was the structured 1:1 mentoring sessions. I had the privilege of sitting down with three ecosystem leaders, and each conversation gave me critical, actionable guidance for CareSight:

  • Saurabh Kumar (Principal at Sure Valley Ventures): Saurabh was incredibly precise about what VCs are looking for in the current market. We discussed how to position CareSight’s privacy-first, AI-powered monitoring systems for elder care, and his feedback on what investors are looking for in terms of traction and tech differentiation was razor-sharp.
  • Menno Axt (Head of Platform at Dogpatch Labs & NDRC): Menno brought an invaluable platform-thinking and ecosystem perspective. We mapped out how CareSight can leverage regional networks, transition from pilots to system-wide adoption, and optimize our platform thinking.
  • Faye Walsh Drouillard (Partner at WakeUp Capital): Faye provided the kind of honest, direct, and impact-focused conversation that early-stage founders need. We focused on funding strategies and the realities of building responsible tech in a regulated care environment.

The Power of Hallway Conversations

While the scheduled sessions were exceptional, the informal conversations in the corridors and over lunch were just as impactful. I had enlightening chats and connected with fellow founders and operators, including Michelle Mead (Familitime / Mykidstime.com), Emer Mugisha (Cyberminds), Dara Cosgrove (InterTradeIreland), Sarah Walker (Enterprise Ireland), Johanna Herfter (CrewCut), and Blessing Fortune. Every single person in that room was building something real, and the peer-to-peer exchange was incredibly grounding.

Sharing our journeys and connecting with peers facing similar technical, commercial, and operational paths reinforced the importance of the community we are building. For CareSight-where we are developing a privacy-focused, AI-powered monitoring system enhancing safety in elder care environments-this shared energy was extremely reassuring.

World-Class Speakers: Pure Signal, No Noise

The main stage featured founders who have been in the trenches and exited, and VCs actively writing checks. The panels addressed the hard realities of fundraising, GTM execution, and product-market fit. Hearing from leaders like Áine Kerr (Storyful & Kinzen), Dee Coakley (Boundless), Katie Farrell (Squid), and Aisling Browne (Glitch) provided a masterclass in resilient building.

A special thanks to Lorraine Curham (Founder of Fierce and Head of Early-Stage Talent at Dogpatch Labs) for creating a space that actually matters. This is the room every woman founder in Ireland needs to be in.

What’s Next for CareSight?

Leaving Dogpatch Labs, I felt sharper, more connected, and highly motivated to execute. At CareSight, we are working on privacy-focused monitoring systems that enhance elder care safety without intrusive video feeds. The insights gained from Fierce Summit will directly guide our regulatory roadmap and upcoming funding round.

If you are an investor or healthcare partner interested in how edge AI and privacy-by-design are redefining elder care, I would love to connect and share more about what we are building at CareSight.

Digital Health Trends and Patient-Centric Design

At the Fierce Summit 2026, CareSight's founders highlighted the shifting expectations of healthcare providers and patients. Digital health is moving away from basic data-logging apps and toward integrated, patient-centric platforms that support clinical decisions. CareSight's AI platform integrates patient health records, remote sensor data, and medication schedules, providing clinicians with real-time dashboards to monitor high-risk patients and intervene early.

The summit discussions also focused on the challenges of securing reimbursement for digital therapeutics, emphasizing the need for robust clinical validation and proof of cost-effectiveness to convince public and private payers to adopt these tools.

Frequently Asked Questions

What is CareSight's primary product?

CareSight provides a clinical remote-monitoring platform that integrates real-time patient vitals and health data to help clinical teams manage chronic disease patients proactively.

What were the main themes of the Fierce Summit 2026?

Key themes included the growth of digital therapeutics, artificial intelligence in patient-centric care, data security compliance, and reimbursement strategies for digital health platforms.

How does remote patient monitoring benefit healthcare systems?

By enabling early intervention, remote monitoring reduces hospital readmission rates, lowers the cost of managing chronic conditions, and improves patient quality of life.

Biotech Incubation and Funding Access

For early-stage digital health and MedTech founders, accessing seed capital and supportive incubation networks is the biggest challenge to scaling. Forums like the Fierce Summit are crucial in providing visibility and mentorship to underrepresented tech leaders. Promoting collaborative ecosystems that connect healthcare startups with established clinical partners is vital to drive healthcare innovation.

About the Author
Sreepriya Prasannan

Sreepriya Prasannan

Writer at Priya Life Science · Industry

Sreepriya Prasannan is the Founder and Lead Editor of Priya Life Science. With a deep passion for the Irish pharmaceutical and MedTech sectors, she specializes in sharing actionable career insights, digital regulatory trends, and GMP compliance strategies.

Discussion
No comments yet. Be the first to share your thoughts!
Leave a Comment